Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Viruses 2014, 6(1), 243-263; doi:10.3390/v6010243
Review

Gene Therapy Strategies to Exploit TRIM Derived Restriction Factors against HIV-1

1
, 2
 and 1,*
Received: 24 October 2013; in revised form: 20 December 2013 / Accepted: 6 January 2014 / Published: 14 January 2014
(This article belongs to the Special Issue Gene Therapy for Retroviral Infections)
View Full-Text   |   Download PDF [455 KB, uploaded 14 January 2014]   |   Browse Figures
Abstract: Restriction factors are a collection of antiviral proteins that form an important aspect of the innate immune system. Their constitutive expression allows immediate response to viral infection, ahead of other innate or adaptive immune responses. We review the molecular mechanism of restriction for four categories of restriction factors; TRIM5, tetherin, APOBEC3G and SAMHD1 and go on to consider how the TRIM5 and TRIMCyp proteins in particular, show promise for exploitation using gene therapy strategies. Such approaches could form an important alternative to current anti-HIV-1 drug regimens, especially if combined with strategies to eradicate HIV reservoirs. Autologous CD4+ T cells or their haematopoietic stem cell precursors engineered to express TRIMCyp restriction factors, and provided in a single therapeutic intervention could then be used to restore functional immunity with a pool of cells protected against HIV. We consider the challenges ahead and consider how early clinical phase testing may best be achieved.
Keywords: HIV; gene therapy; restriction factor; TRIM; cyclophilin; TRIMCyp HIV; gene therapy; restriction factor; TRIM; cyclophilin; TRIMCyp
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Chan, E.; Towers, G.J.; Qasim, W. Gene Therapy Strategies to Exploit TRIM Derived Restriction Factors against HIV-1. Viruses 2014, 6, 243-263.

AMA Style

Chan E, Towers GJ, Qasim W. Gene Therapy Strategies to Exploit TRIM Derived Restriction Factors against HIV-1. Viruses. 2014; 6(1):243-263.

Chicago/Turabian Style

Chan, Emma; Towers, Greg J.; Qasim, Waseem. 2014. "Gene Therapy Strategies to Exploit TRIM Derived Restriction Factors against HIV-1." Viruses 6, no. 1: 243-263.



Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert